- Home
- MRSN vs DPRO Comparison
MRSN vs DPRO Comparison
Compare MRSN & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- DPRO
- Stock Information
- Founded
- MRSN 2001
- DPRO 1998
- Country
- MRSN United States
- DPRO Canada
- Employees
- MRSN N/A
- DPRO N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- DPRO Aerospace
- Sector
- MRSN Health Care
- DPRO Industrials
- Exchange
- MRSN Nasdaq
- DPRO Nasdaq
- Market Cap
- MRSN 34.0M
- DPRO 38.9M
- IPO Year
- MRSN 2017
- DPRO N/A
- Fundamental
- Price
- MRSN $6.75
- DPRO $4.97
- Analyst Decision
- MRSN Strong Buy
- DPRO Strong Buy
- Analyst Count
- MRSN 5
- DPRO 2
- Target Price
- MRSN $5.75
- DPRO $6.50
- AVG Volume (30 Days)
- MRSN 130.5K
- DPRO 7.5M
- Earning Date
- MRSN 08-12-2025
- DPRO 08-12-2025
- Dividend Yield
- MRSN N/A
- DPRO N/A
- EPS Growth
- MRSN N/A
- DPRO N/A
- EPS
- MRSN N/A
- DPRO N/A
- Revenue
- MRSN $34,006,000.00
- DPRO $4,716,450.00
- Revenue This Year
- MRSN N/A
- DPRO $94.01
- Revenue Next Year
- MRSN $1.03
- DPRO $95.14
- P/E Ratio
- MRSN N/A
- DPRO N/A
- Revenue Growth
- MRSN N/A
- DPRO 7.90
- 52 Week Low
- MRSN $6.47
- DPRO $1.55
- 52 Week High
- MRSN $70.75
- DPRO $7.31
- Technical
- Relative Strength Index (RSI)
- MRSN 38.74
- DPRO 53.96
- Support Level
- MRSN $6.55
- DPRO $4.44
- Resistance Level
- MRSN $10.25
- DPRO $6.99
- Average True Range (ATR)
- MRSN 0.70
- DPRO 0.86
- MACD
- MRSN -0.20
- DPRO -0.09
- Stochastic Oscillator
- MRSN 5.41
- DPRO 42.70
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.